Hong Chau Tran Thi, Minh Chau Nguyen Ngoc, Hoang Le Nhat Thanh, Chung The Hao, Voong Vinh Phat, Nguyen To Nguyen Thi, Ngoc Nguyen Minh, Tuan Ha Manh, Chau Ngoc Tang Le, Kolader Marion-Eliette, Farrar Jeremy J, Wolbers Marcel, Thwaites Guy E, Baker Stephen
Pediatr Infect Dis J. 2018 Jan;37(1):35-42. doi: 10.1097/INF.0000000000001712.
Probiotics are the most frequently prescribed treatment for children hospitalized with diarrhea in Vietnam. We were uncertain of the benefits of probiotics for the treatment of acute watery diarrhea in Vietnamese children.
We conducted a double-blind, placebo-controlled, randomized trial of children hospitalized with acute watery diarrhea in Vietnam. Children meeting the inclusion criteria (acute watery diarrhea) were randomized to receive either 2 daily oral doses of 2 × 10 CFUs of a local probiotic containing Lactobacillus acidophilus or placebo for 5 days as an adjunct to standard of care. The primary end point was time from the first dose of study medication to the start of the first 24-hour period without diarrhea. Secondary outcomes included the total duration of diarrhea and hospitalization, daily stool frequency, treatment failure, daily fecal concentrations of rotavirus and norovirus, and Lactobacillus colonization.
One hundred and fifty children were randomized into each study group. The median time from the first dose of study medication to the start of the first 24-hour diarrhea-free period was 43 hours (interquartile range, 15-66 hours) in the placebo group and 35 hours (interquartile range, 20-68 hours) in the probiotic group (acceleration factor 1.09 [95% confidence interval, 0.78-1.51]; P = 0.62). There was also no evidence that probiotic treatment was efficacious in any of the predefined subgroups nor significantly associated with any secondary end point.
This was a large double-blind, placebo-controlled trial in which the probiotic underwent longitudinal quality control. We found under these conditions that L. acidophilus was not beneficial in treating children with acute watery diarrhea.
在越南,益生菌是腹泻住院儿童最常用的处方治疗方法。我们不确定益生菌对越南儿童急性水样腹泻治疗的益处。
我们在越南对急性水样腹泻住院儿童进行了一项双盲、安慰剂对照、随机试验。符合纳入标准(急性水样腹泻)的儿童被随机分配,每天口服2次,每次2×10CFU含嗜酸乳杆菌的当地益生菌或安慰剂,共5天,作为标准治疗的辅助治疗。主要终点是从第一剂研究药物到第一个无腹泻24小时期间开始的时间。次要结局包括腹泻和住院的总持续时间、每日大便频率、治疗失败、轮状病毒和诺如病毒的每日粪便浓度以及嗜酸乳杆菌定植情况。
每个研究组随机纳入150名儿童。安慰剂组从第一剂研究药物到第一个无腹泻24小时期间开始的中位时间为43小时(四分位间距,15 - 66小时),益生菌组为35小时(四分位间距,20 - 68小时)(加速因子1.09 [95%置信区间,0.78 - 1.51];P = 0.62)。也没有证据表明益生菌治疗在任何预定义亚组中有效,也与任何次要终点无显著关联。
这是一项大型双盲、安慰剂对照试验,其中益生菌经过了纵向质量控制。我们发现在这些条件下,嗜酸乳杆菌对治疗急性水样腹泻儿童无益。